http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Bimergen Energy Engages RedChip Companies to Lead Investor Relations Efforts
-
KLAS Research Spotlight Report: Heidi Health Earns High Scores for Reducing Clinician Documentation Burden
-
Major Online Auction: State-of-the-Art Draslovka Chemical Compound Processing Plant in Mexico
-
Alliance Creative Group completes acquisition of digital media assets
-
NextNav appoints Tim Gray as CFO, moves Chris Gates to development role
-
Alliance Creative Group, Inc. (ACGX) Completes Acquisition of a Dozen Digital Media Assets
-
NextNav Appoints Industry Veteran Tim Gray as Chief Financial Officer
-
PRNEWS Selects Toshiba's Rick Havacko as Person of the Year Winner
-
Cardless Raises $60M Series C On Heels of Coinbase & Bilt Partnerships, Supercharging Effort to Transform the Credit Card Industry
-
The Coffee Cocktail of a Generation: Mr Black Espresso Martini Fest Marks Year Four
-
Green Rain Energy Holdings (OTC: $GREH) Taps Wallace Engineering For Development & Co-Ownership Of Selected EV Charging Projects
-
Trinity Capital Inc. Provides $45 Million in Growth Capital to Rapid Micro Biosystems, Modernizing Healthcare Industry Practices
-
Trailbreaker Resources Mobilizes Exploration Team to Atsutla Gold Project, Northwestern BC
-
SeaPak Donates $25,000 to Ocean Conservancy in Honor of Sea Otter Awareness Week
-
XRP Tundra Presale Provides Two Tokens at Fixed $0.028 Phase Two Price
-
BTQ Technologies gets approval to list shares on NASDAQ
-
BTQ Technologies Receives Approval to List on Nasdaq
-
BridgeBio to Present Additional Cardiovascular Outcomes Data from ATTRibute-CM at the HFSA Annual Scientific Meeting 2025
-
Palatin Earns €5.5 Million ($6.5 Million) Milestone Payment in Retinal Disease Collaboration with Boehringer Ingelheim
-
First Phosphate closes third tranche of private placement for $4.7M
-
First Phosphate Closes Third Tranche of Oversubscribed Private Placement
-
Ionis reports positive results for Alexander disease drug zilganersen
-
Ionis announces positive topline results from pivotal study of zilganersen in Alexander disease
-
Schneider Electric Puts Energy Resilience at the Center of Climate Week NYC 2025
-
BD partners with Henry Ford Health on pharmacy automation system
-
BD and Henry Ford Health Sign Pharmacy Automation Partnership to Revolutionize Medication Storage and Prescription Delivery
-
Crystal Art Gallery Increases Ecommerce Fulfillment 5x with Descartes Sellercloud™
-
Mavon Leverages Amazon Bedrock to Bring Property Management AI to Affordable Housing
-
Full-Color AR Glasses Reach an Inflection Point! JBD Teams Up with Applied Materials and RayNeo to Break Through AR Display Quality Bottlenecks
-
HTX Opens Trading for ASTER (Aster)
-
accesso® Powers Game-Changing Guest Experiences at IAAPA Expo Europe 2025
-
Aelis Farma Reports 2025 Half-Year Financial Results and Presents Progress and Development Outlook
-
Bitcoin Investors Join XRP Tundra Presale With Target Launch Price of $2.50
-
No KYC 100x Leverage 100% Deposit Bonus, Crypto Futures Trading Made Easy on BexBack
-
Tracer Launches Initial Exchange Offering on Coinstore: Building a Trusted RWA Ecosystem for Carbon Removal
-
Goldragon Launches Next-Gen GameFi Ecosystem on BNB Chain with RWA-Backed Staking & Governance Tools
-
Ozak AI Presale Crosses $3.3M—Price Prediction Points to Explosive Gains
-
XRP Tundra presale opens at $0.01, offering dual tokens across XRPL and Solana with audited security measures.
-
Disney’s Kimmel suspension shows Trump’s increasing grip over media
-
PreveCeutical Announces Mailing and Filing of Annual General and Special Meeting Materials in Connection with a Proposed Arrangement with BioGene Therapeutics
-
FDA approves Merck's subcutaneous KEYTRUDA QLEX across 38 cancer indications
-
FDA Approves Merck’s KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph) Injection for Subcutaneous Use in Adults Across Most Solid Tumor Indications for KEYTRUDA® (pembrolizumab)
-
Millennial Enters into Investor Relations Agreements to Raise Profile with Global Investment Community
-
CharCoin Launches on Solana: A Meme Coin Turning Every Transaction Into Global Good
-
Edimakor V4.3.0 Unveils AI Video and Enhanced Image Creation with Veo 3 & Nano Banana
-
Skywork.ai Redefines Enterprise Productivity with DeepResearch AI Agents Built for Real-World Industry Demands
-
Moderna Announces First Made-in-Canada mRNA Vaccines Delivered to Canadian Provinces and Territories
-
Vishay to exhibit AI and EV components at PCIM Asia 2025
-
Vishay Intertechnology to Showcase Solutions for AI and EV Applications at PCIM Asia 2025
-
Bark and Shibo Recognized Among All-Time Leading Crypto Voices, as Doginal Dogs Gets the NFT Spotlight
